Consumption of highly processed food linked to psoriasis flare-up
Bharti Jayshankar December 4, 2024: The link between highly ultra-processed food (UPF) and various health issues such as obesity, diabetes, cardiovascular risks and.
Bharti Rana Jayshankar – Founder
She brings in more than 30 years of experience in content building, architecture, writing, editing and storytelling. Ms Jayshankar has worked in the Economic Times daily, IBT Times, Investopedia and more than a dozen content firms as a content strategist and planner.
Jay Shankar – Co-founder
He has almost three decades of experience in journalism. He has worked with national dailies such as ET, Indian Express, The Pioneer, The Hindu, Agence France Presse and Bloomberg.
Bharti Jayshankar December 4, 2024: The link between highly ultra-processed food (UPF) and various health issues such as obesity, diabetes, cardiovascular risks and.
Bharti Jayshankar December 3, 2024: A study conducted by researchers at Johns Hopkins University revealed concerning links between levothyroxine—a commonly prescribed medication for.
Bharti Jayshankar December 3, 2024: If you are overweight and have accumulated body fat around your belly in your middle years then you.
Swati Deshmukh December 2, 2024: The human papillomavirus (HPV) vaccine is significantly reducing cervical cancer deaths in the United States, finds a study..
Bharti Jayshankar December 2, 2024: A recent study by University College London (UCL) has revealed that the decrease in brain volume observed in.
Bharti Jayshankar November 30, 2024: A study done by the University of Texas MD Anderson Cancer Center revealed that some breast cells in healthy.
Bharti Jayshankar November 29, 2024: Certain hormone replacement therapy (HRT) pills significantly elevate the risk of heart disease and serious blood clots in.
Bharti Jayshankar November 29, 2024: Around half a billion people live with asthma and chronic obstructive pulmonary disease (COPD). The Global Burden of.
Switzerland’s F. Hoffmann-La Roche AG will buy US-based biopharmaceutical company Poseida Therapeutics for $1.5 billion, according to a statement from the Basel-headquartered company.
Cassava Sciences Inc., a US-based biotechnology firm, announced its controversial experimental oral molecule to treat Alzheimer’s Disease has failed in last-stage trials.
We use cookies to improve your experience on our site. By using our site, you consent to cookies.
Manage your cookie preferences below:
Essential cookies enable basic functions and are necessary for the proper function of the website.
Statistics cookies collect information anonymously. This information helps us understand how visitors use our website.
Google Analytics is a powerful tool that tracks and analyzes website traffic for informed marketing decisions.
Service URL: policies.google.com